• / Free eNewsletters & Magazine
  • / My Account
Home>It’s Never Too Early: Roth 401(k)s and Other Fun Stuff

It’s Never Too Early: Roth 401(k)s and Other Fun Stuff

Morningstar Articles

Thu, 3 Apr 2014

Progenics Pharmaceuticals PGNX announced on March 6 that it would backtrack and reformulate the oral version opioid bowel dysfunction drug MNTX to make it more effective. If successful, the firm could file for its approval in late 2009. Our fair value

Related Videos

  1. Picks and Strategies to Navigate Today's Market

    Roundtable report: Morningstar strategists offer up their best ideas for a fully valued, low-yield market with few attractive choices.

©2017 Morningstar Advisor. All right reserved.